We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Marina Biotech Presents Long Term Toxicology Data for CEQ508 FAP Drug Candidate

News   Apr 05, 2011

 
Marina Biotech Presents Long Term Toxicology Data for CEQ508 FAP Drug Candidate
 
 
 

RELATED ARTICLES

Treating Blood Cancers With a Low-cost Arthritis Drug

News

A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers, according to a new study by the University of Sheffield.

READ MORE

Potential Carcinogen Present in High Levels in E-cigarette Liquids

News

A potential carcinogen called "pulegone" is present in high levels in electronic cigarette liquids and smokeless tobacco products, according to a new study.

READ MORE

Some Cancer Drugs Don’t Work by Hitting Their Targets

News

Some cancer drug candidates in clinical trials kill cancerous cells through off-target effects instead of by interacting with their intended molecular targets, according to new study findings.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE